DRMA · Dermata Therapeutics, Inc.
$1.72
+0.09 (+5.52%)
At close · Aug 25
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of historical and expected operating losses and net operating cash flow deficits, there is substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the financial statements, which is not alleviated by management's plans.”View the 10-Q filed Aug 11, 2026
Market Cap
$6.92M
Shares
4.02M
Dermata Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Dermata Therapeutics, Inc. (DRMA), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.